Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FAVIPIRAVIR vs FEBUXOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FAVIPIRAVIR vs FEBUXOSTAT: Safety Overview

Metric FAVIPIRAVIR FEBUXOSTAT
Total FAERS Reports 558 5,843
Deaths Reported 113 404
Death Rate 20.3% 6.9%
Hospitalizations 199 1,755
Average Patient Age 54.5 yrs 66.7 yrs
% Female Patients 33.4% 31.6%
FDA Approval Date N/A Dec 19, 2023
Manufacturer N/A Novadoz Pharmaceuticals LLC
Route N/A ORAL
Marketing Status N/A Prescription